Co-Diagnostics, Inc. Share Price
NASDAQ: CODX | Micro CapCo-Diagnostics, Inc. Stock Performance
Open $1.13 | Prev. Close $1.09 | Circuit Range N/A |
Day Range $1.08 - $1.14 | Year Range $0.17 - $13.51 | Volume 2,498 |
Average Traded $1.11 |
Co-Diagnostics, Inc. Share Price Today
As of 21 August 2026, Co-Diagnostics, Inc.'s share price is $1.16. The stock opened at $1.13, compared to its previous close of $1.09. During today's trading session, Co-Diagnostics, Inc.'s share price traded between $1.08 and $1.14, with an average price of $1.11. Over the past 52 weeks, the stock has recorded a high of $13.51 and a low of $0.17. In terms of performance, Co-Diagnostics, Inc.'s share price has declined by 52.26% over the last six months and is up 358.50% on a year-on-year basis.
Co-Diagnostics, Inc. Share Price Chart
Co-Diagnostics, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.54M | PE Ratio (TTM) -0.03 | Dividend Yield N/A |
EPS (TTM) $-35.25 | Revenue (TTM) $622489.00 | Return On Equity (TTM) -227.33% |
Profit Margin -7533.62% | Debt to Equity 0.17 | Quarterly Earnings Growth YoY 39.29% |
Co-Diagnostics, Inc. Quarterly Profit & Loss
All figures in USD
Co-Diagnostics, Inc. Annual Profit & Loss
All figures in USD
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.
Co-Diagnostics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.48 | $1.08 | -26.03% |
Jul 2026 | $3.40 | $1.46 | -51.97% |
Jun 2026 | $6.83 | $3.04 | -62.97% |
May 2026 | $1.53 | $8.21 | +419.62% |
Apr 2026 | $1.62 | $1.58 | -16.40% |
Mar 2026 | $3.60 | $1.89 | -22.22% |
Jan 2026 | $5.26 | $2.43 | +1,346.43% |
Dec 2025 | $0.35 | $0.17 | -54.96% |
Nov 2025 | $0.45 | $0.37 | -20.64% |
Oct 2025 | $0.35 | $0.47 | +37.03% |
Sep 2025 | $0.32 | $0.34 | +4.57% |
Aug 2025 | $0.25 | $0.33 | +29.64% |
CODX Share Price FAQs
What is Co-Diagnostics, Inc. share price today?
What is the 52 week high and 52 week low of Co-Diagnostics, Inc. stock?
What is CODX's market capitalisation today?
What is CODX's net income for the last quarter?
What is the 5 year returns of CODX?
What is the high & low stock price of CODX today?
Can I buy CODX shares in India?